Stay updated on Idasanutlin Combo Therapy in AML Clinical Trial
Sign up to get notified when there's something new on the Idasanutlin Combo Therapy in AML Clinical Trial page.

Latest updates to the Idasanutlin Combo Therapy in AML Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedA new NIH grant/contract funding note was added to the page, and the site revision was updated to v3.6.6 (replacing v3.6.5), reflecting funding attribution and a version bump.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check37 days agoChange DetectedThe page now reflects a new revision version (v3.6.5), indicating a platform update rather than a change to the study information.SummaryDifference0.0%

- Check51 days agoChange DetectedThe page revision was updated from v3.6.3 to v3.6.4, indicating a small platform/template update; no substantive study information appears to have changed.SummaryDifference0.0%

- Check73 days agoChange DetectedThe page now shows Revision: v3.6.3, replacing the previous v3.6.2. This appears to be a minor site update and does not change the study content or results.SummaryDifference0.0%

- Check80 days agoChange DetectedThe page revision was updated from v3.6.0 to v3.6.2, indicating a newer version of the page.SummaryDifference0.0%

- Check94 days agoChange DetectedThe page now indicates that recruitment has ended and adds new help sections for reading the study record and joining the study, while reorganizing the Intervention/Treatment heading to reflect current content.SummaryDifference0.4%

Stay in the know with updates to Idasanutlin Combo Therapy in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Idasanutlin Combo Therapy in AML Clinical Trial page.